BARDA Industry Day
EUAs for BARDA-supported SARS CoV-2 Diagnostic Tests
Diagnostic Test Kits Shipped by BARDA-Supported Partners
COVID-19 CoronaWatch Meeting Request Submissions
If you are interested in partnering with the federal government on a COVID-19 medical countermeasure, submit your ideas to a platform that reaches a host of potential federal partners.
To spur innovation, BARDA has issued its business-friendly, streamlined Easy Broad Agency Announcement (EZ-BAA) to support a number of new medical countermeasures to fight the COVID-19 outbreak.
Novel Coronavirus EZ-BAA
BARDA is investing in an array of medical countermeasures to
diagnose, treat, or protect against the 2019 novel coronavirus under the BARDA Broad Agency Announcement (BAA-18-100-SOL-00003).
COVID-19 MCM Portfolio
Rapidly deploying test kits to Americans
BARDA and Luminex Corporation partner to expedite development of COVID…
BARDA and Luminex Corporation enter into a public-private partnership…
BARDA Partners with University of Pennsylvania Researchers to Develop…
Every American can make a difference in our country's response to COVID-19.Learn more about how you can contribute to the fight.